Stock Market Reviews

IONS (Ionis Pharmaceuticals, Inc.) News

Get the latest news, insights, and market updates on IONS (Ionis Pharmaceuticals, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.

• JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won
  Alnylam stock slipped Monday after its fourth-quarter preannouncement ahead of the J.P. Morgan Healthcare Conference.
  Jan 12, 2026 - $IONS
• Why Ionis Pharmaceuticals (IONS) Is Up 5.1% After Hepatitis B Drug Hits Phase 3 Goals And What's Next
  Earlier this week, GSK and Ionis Pharmaceuticals reported that their antisense drug bepirovirsen achieved primary endpoints in two Phase 3 trials for chronic hepatitis B, showing a statistically significant and clinically meaningful functional cure rate that will underpin planned global regulatory filings in the coming months. These results also activate an economic opportunity for Ionis, with eligibility for up to US$150,000,000 in additional milestone payments from GSK plus tiered...
  Jan 8, 2026 - $IONS
• Cathie Wood Dumps $12.7 Million Worth of Meta Stock Amid Ray-Ban Smart Glasses Delay, Ark Loads Up On This Gaming Platform
  On Tuesday, Cathie Wood-led Ark Invest made significant trades involving Meta Platforms Inc. (NASDAQ:META), Roblox Corp. (NYSE:RBLX), and Kodiak AI Inc. (NASDAQ:KDK). The Meta Platforms Trade Ark Invest executed a notable divestment in Meta Platforms on Tuesday, selling a total of 19,316 shares across ARK Blockchain & Fintech Innovation ETF (BATS:ARKF), ARK Innovation ETF (BATS:ARKK), and ARK Next Generation Internet ETF (BATS:ARKW). The decision comes as Meta faces challenges with its Ray-Ban s
  Jan 8, 2026 - $IONS
• Dow Jones Futures Fall; Lockheed, Defense Giants Bounce On $1.5 Trillion Trump 'Dream Military'
  Futures fell. Lockheed Martin and other defense giants jumped on Trump's proposed $1.5 trillion "Dream Military" budget.
  Jan 8, 2026 - $IONS
• Dow Jones Futures Fall; Eli Lilly Breaks Out, Google Trumps Apple
  The S&P 500 and Dow reversed from highs Wednesday, while the Nasdaq pared gains. Eli Lilly and Google flashed buy signals.
  Jan 8, 2026 - $IONS
• GSK, Ionis claim study success for RNA-based hepatitis B drug
  The companies didn’t provide details, but said global regulatory filings are now planned for the therapy, an oligonucleotide meant to provide “functional cures” for chronic hepatitis B infections.
  Jan 7, 2026 - $IONS
• Ionis partner GSK announces positive topline results from B-Well 1 and B-Well 2 Phase 3 studies for bepirovirsen, a potential first-in-class medicine for chronic hepatitis B
  CARLSBAD, Calif., January 07, 2026--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced positive results from two pivotal Phase 3 studies, B-Well 1 and B-Well 2, evaluating the safety and efficacy of bepirovirsen, an investigational antisense oligonucleotide (ASO) for the treatment of chronic hepatitis B (CHB). The studies included over 1,800 patients from 29 countries. GSK licensed bepirovirsen from Ionis and the two companies have collaborated on its development.
  Jan 7, 2026 - $IONS
• GSK Reports 'Positive' Phase 3 Results From Chronic Hepatitis B Studies
  Ionis Pharmaceuticals (IONS) said early Wednesday its partner GSK (GSK) reported "positive" results
  Jan 7, 2026 - $IONS
• Ionis to present at 44th Annual J.P. Morgan Healthcare Conference
  CARLSBAD, Calif., January 06, 2026--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 44th Annual J.P. Morgan Healthcare Conference at 8:15 a.m. PT on Tuesday, January 13, 2026.
  Jan 6, 2026 - $IONS
• Ardelyx (ARDX) Moves 5.5% Higher: Will This Strength Last?
  Ardelyx (ARDX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
  Jan 5, 2026 - $IONS